ATLAS fair value
ATLAS has no fair value for this stock today.
Zai Lab share price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Hong Kong Exchanges (HKEX) · Hong Kong SAR China
Prices as of Oct 27, 2026 · HKD
ATLAS has no fair value for this stock today.
47%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Zai Lab a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between HK$16.07 and HK$20.09; in 9 out of 10, between HK$13.17 and HK$24.50. Estimated annual volatility is 66%.
ATLAS does not publish a fair value for 9688.HK right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 9688.HK has traded between HK$12.31 and HK$21.42. Today it is 15.1% below that high and 48% above its low.
Its beta is 0.72: it tends to move less than the market.
Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
Want to see everything about Zai Lab?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
47%: close to a coin flip. In half of the simulated outcomes, 9688.HK ends the month between HK$16.07 and HK$20.09.
Zai Lab's market capitalization is HK$22.2B. We do not show a P/E because it has no positive earnings to base one on.
ATLAS estimates annual volatility at 66%. In a typical month, half of the outcomes end between HK$16.07 and HK$20.09.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy